Concepedia

Martin Hénault

MH

19

Publications

1K

Citations

16

H-Index

2005

Active since

Affiliations

Merck Canada Inc. (Canada)(Current)

Novartis (United States)

Novartis Institutes for BioMedical Research

Novartis (Switzerland)

Eli Lilly (United States)

Martin Hénault is an author at Merck Canada Inc. (Canada) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2005–2024

19

Publications

19

DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery

Chaoyang Ye, Daniel Ho, Marilisa Neri et al. · Nature Communications · 2018 · 231 citations · Full text

Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation

Cheryl Carson, Pichai Raman, Jennifer Tullai et al. · PLoS ONE · 2015 · 108 citations · Full text

, , +16

CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing’s sarcoma

Nathan T. Ross, Felix Lohmann, Seth Carbonneau et al. · Nature Chemical Biology · 2019 · 85 citations · Full text

, , +9

DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance

Martin Schröder, Martin Renatus, Xiaoyou Liang et al. · Nature Communications · 2024 · 71 citations · Full text

Secretion of Proinflammatory Cytokines and Chemokines during Amphotericin B Exposure Is Mediated by Coactivation of Toll-Like Receptors 1 and 2

Raymund R. Razonable, Martin Hénault, Linda N. Lee et al. · Antimicrobial Agents and Chemotherapy · 2005 · 62 citations · Full text

, , +19

Rows per page

1–5 of 19